ArticleParticle and fibre toxicology2026
Pulmonary toxicity of micro- and nano polyethylene particles following intratracheal instillation in rats.
Article in Particle and fibre toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicro- and nano-sized polyethylene plastics (PE-MPs and PE-NPs) are emerging as potential risk factors for pulmonary disease and risk assessment. Currently, their is no direct evidence suggests this appreciable health risk extends to humans. Furthermore, the toxicological evaluation of PE-MPs and PE-NPs is insufficient to support their safe use.
methodsThis study was aimed to characterize the toxicity of PE-MPs and PE-NPs after 13 weeks of intratracheal instillation in Sprague-Dawley (SD) rats and to assess the reversibility of any effects during a 4-week recovery period. Exposure levels for PE-MPs and PE-NPs were set at 0, 40, 80, and 120 μg per rat once a week.
resultsThe results indicated that the treatment administration resulted in observable lung tissue alterations. Inflammatory cells were present in the perivascular and peribronchiolar regions in both sexes at ≥ 40 μg per rat in the PE-MPs and PE-NPs-treated groups, indicating a biological response that can turn into toxicity. Additionally, thickened alveolar ducts and alveolar epithelial hyperplasia were noted in males at 120 μg per rat PE-MPs, in males at ≥ 80 μg per rat PE-NPs, and in females at ≥ 40 μg per rat PE-MPs and PE-NPs-treated groups. Interestingly, when instilled repeatedly with both sizes of polyethylene particles, IL-1β and TNF-α secretion was significantly more enhanced in female rats compared to male rats. At the same time, the pulmonary level of IL-6 increased more clearly in male rats than in female rats. The pulmonary level of C-reactive protein, a marker for acute inflammation, was increased in all treated groups.
conclusionThese findings suggest that the lowest-observed-adverse-effect level (LOAEL) for PE-MPs and PE-NPs based on repeated exposures is below 40 μg per rat for both sexes. However, the toxicological data for PE-MPs and PE-NPs remain insufficient to confirm their safety, and further research is necessary to evaluate their potential risks to human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.